Furthermore, sFLT1, a soluble Flt1 protein, is an antiangiogenic factor originating from the placenta [30], and its overproduction is an important event that drives the clinical features of PE, such as hypertension. This evidence concerns the gene FLT1 and hypertensive disorder.